Cashu
MetaVia Strengthens IP Portfolio for Innovative Cardiometabolic Disease Solutions with Vanoglipel
about 8 hours ago
Stocks
Health Care
mtva
MetaVia
NASDAQ: MTVA
+0.03 (+1.86%)
1.64
USD
At close at Mar 13, 20:10 UTC
Latest MetaVia News
prnewswire.com
MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
1 day ago
prnewswire.com
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
9 days ago
prnewswire.com
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
24 days ago
prnewswire.com
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
28 days ago
prnewswire.com
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
about 2 months ago
prnewswire.com
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
about 2 months ago
prnewswire.com
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
2 months ago
prnewswire.com
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
3 months ago
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
3 months ago
prnewswire.com
MetaVia Inc. Announces 1-for-11 Reverse Stock Split
3 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.